Takeda Pharma

Following a dip in the first-quarter operating profit announced by Takeda, which is being attributed to the loss of US exclusivity for its blockbuster cancer drug and a lacking pipeline, it may find a saving grace in its recent merger with Shire more


The first allogenic stem cell therapy — Alofisel (darvadstrocel) from TiGenix and Takeda Pharmaceutical Company — has received marketing authorisation approval from the EC for the treatment of complex perianal fistulas in Crohn’s disease more


Takeda Pharmaceutical Company has announced its intention to acquire the advanced biopharmaceutical company, TiGenix. more


With festivities and holidays galore during the latter part of December we thought it would be a good idea to briefly run through some of the pharma news that came out in the run up to Christmas. more


Joachim Koerner, director e-Device, R&D Prescription Division, Aptar Pharma, discusses intranasal drug delivery and how an integrated electronic lockout device can assist with patient adherence and help prevent drug misuse. more


A collaboration has been announced between AstraZeneca and Takeda Pharmaceutical Company for the development and commercialisation of an alpha-synuclein antibody, MEDI1341, as a potential treatment for Parkinson’s disease. more


Participating companies are AstraZeneca, GSK, Janssen R&D, Lilly, Pfizer, Takeda and UCB. more

Dycem is a world leading manufacturer and supplier of contamination control floor solutions for critical environments. The products produced are solely manufactured in the UK at its Bristol site and are sold globally in more than 50 countries to many more